• December 3, 2018

    Jeff Aronin is Named Innovator of the Year by Best in Biz

    With its highest honor, a Gold level award, [...]

  • October 19, 2018

    Paragon Biosciences Announces $71.8 Million in New Investment for Portfolio Company Castle Creek Pharma

    Paragon organizes new investment from Fidelity Management & [...]

  • October 19, 2018

    Crain’s Chicago Business: “Chicago-based Biotech Incubator Raises $71.8 Million”

    October 19, 2019 – Paragon Biosciences CEO Jeff Aronin [...]

  • October 1, 2018

    Jeff Aronin Named One of the 20 Most Influential Leaders in Healthcare for 2018

    Paragon CEO Jeff Aronin Recognized by Insights Care [...]

  • August 21, 2018

    Paragon Biosciences Announces Skyline Biosciences as the Newest Addition to Its Growing Portfolio of Companies

    CHICAGO – August 21, 2018 – Paragon Biosciences [...]

  • August 14, 2018

    Emalex Biosciences Acquires Psyadon Pharmaceuticals to Develop Novel Treatment for Pediatric Tourette Syndrome

    CHICAGO – August 14, 2018 – Biopharmaceutical company [...]

  • August 9, 2018

    Castle Creek Pharmaceuticals Receives FDA Fast Track Designation for Diacerein 1% Ointment for Treatment of Epidermolysis Bullosa Simplex

    Biopharmaceutical company currently evaluating diacerein 1% ointment (CCP-020) [...]

  • June 25, 2018

    Castle Creek Pharmaceuticals Announces First Patient with Epidermolysis Bullosa Enrolled in Pharmacokinetics Study of Diacerein 1% Ointment

    New multi-center Phase 1 study expected to enroll [...]